Clinical Trial

CFTR Modulators in Pregnancy and Postpartum

Recruiting
View on ClinicalTrials.gov →
Summary
Observational study on women with Cystic Fibrosis treated with CFTR modulators during pregnancy and postpartum and their children. Registration on maternal health parameters and effects of CFTR-modulators in the newborn infant as well as effects of exposure through mother's own milk.
Trial Details
NCT Number NCT06302270
Lead Sponsor Region Stockholm
Collaborators: Karolinska Institutet
Conditions Cystic Fibrosis
Enrollment 75 participants
Start Date 2024-03-15
Primary Completion 2034-01-31 (estimated)
Study Completion 2039-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-08